Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
0000000000000022
Formula: C13H14F2N6O2
also known as MS-209
PubMed PMID: 17553039
UNC2281 inhibits steady-state Mer kinase phosphorylation with an IC50 value of 22 nM
Edoxaban - CAS# 480449-70-5 somer 0000000000000022Edoxaban (INN, codenamed DU 176b, trade name Lixiana) is a potent, selective factor Xa inhibitor, which has good oral bioavailability. Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It is being developed by Daiichi Sankyo. It was approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower limb orthopedic surgery. It was also approved by the FDA in January 2015 for the prevention of